Homogeneous enzyme immunoassay for proteins employing β-galactosidase
✍ Scribed by Ian Gibbons; Carl Skold; Gerald L. Rowley; Edwin F. Ullman
- Publisher
- Elsevier Science
- Year
- 1980
- Tongue
- English
- Weight
- 287 KB
- Volume
- 102
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
✦ Synopsis
A homogeneous enzyme immunoassay method for proteins is described. The assay components include a protein antigen-P-galactosidase conjugate, antiprotein antibody, and a synthetic macromolecular substrate. When antibody binds to the conjugate, enzyme activity is inhibited up to 95% because of steric exclusion of the substrate. Free-protein antigen competes for antibody, thus preventing inhibition. The extent of inhibition is related to the concentration of protein analyte. The assay is simple to perform, highly sensitive, and is generally useful for proteins with wide structural variations.
📜 SIMILAR VOLUMES
A unique homogeneous enzyme immunoassay used for the determination of haptens and macromolecular antigens has been developed. It consists of avidin-antigen conjugate, anti-ligand antibody, and biotin enzyme (propionyl-CoA carboxylase). The immunological reaction of the conjugate with antibodies spec
## Abstract A convenient homogeneous enzyme immunoassay for estradiol is described. Unlike heterogeneous immunoassays, which require time‐consuming separation steps or expensive automated systems, homogeneous immunoassays, wherein all reagents are freely suspended in bulk solution, can be simple an
A specific and sensitive &galactosidase immunoassay is described. A cyclic AMP-fi-galactosidase conjugate is used as the labeled cyclic AMP derivative in a competitive binding assay. By determining the ,%galactosidase activity, the concentration of the antibody-bound conjugate is easily detected. Cy
A new homogeneous enzyme immunoassay for the determination of macromolecular antigens has been developed based upon competitive enzyme inhibition using hybrid antibodycontaining anti-ligand and anti-enzyme inhibitory antibodies. The hybrid antibody was prepared by the reaction of anti-glucose-6-pho